Trial Profile
Upstream Use of Aliskiren in Hypertensive Haemodialysis Patients: Effects on Cardiovascular Outcomes
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2017
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms RAAS-block dial
- 16 Jul 2012 New trial record